| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain | 42 | 2023 | 1555 | 3.180 |
Why?
|
| Neurosciences | 11 | 2023 | 27 | 2.830 |
Why?
|
| Neuroimaging | 10 | 2021 | 153 | 2.800 |
Why?
|
| Information Dissemination | 13 | 2019 | 116 | 2.710 |
Why?
|
| Magnetic Resonance Imaging | 61 | 2023 | 2167 | 1.800 |
Why?
|
| Databases, Factual | 12 | 2016 | 868 | 1.710 |
Why?
|
| Database Management Systems | 7 | 2018 | 19 | 1.490 |
Why?
|
| Computational Biology | 8 | 2024 | 356 | 1.440 |
Why?
|
| Brain Mapping | 30 | 2019 | 232 | 1.420 |
Why?
|
| Reproducibility of Results | 22 | 2025 | 1649 | 1.320 |
Why?
|
| Editorial Policies | 3 | 2018 | 55 | 1.240 |
Why?
|
| Information Storage and Retrieval | 6 | 2019 | 60 | 1.230 |
Why?
|
| Internet | 12 | 2016 | 469 | 1.130 |
Why?
|
| Cognition | 11 | 2022 | 484 | 1.110 |
Why?
|
| Cerebral Cortex | 17 | 2019 | 260 | 1.100 |
Why?
|
| Image Processing, Computer-Assisted | 30 | 2021 | 659 | 1.060 |
Why?
|
| Periodicals as Topic | 5 | 2017 | 175 | 1.050 |
Why?
|
| Software | 14 | 2025 | 389 | 1.020 |
Why?
|
| Schizophrenia | 15 | 2019 | 265 | 0.990 |
Why?
|
| Nootropic Agents | 2 | 2018 | 10 | 0.980 |
Why?
|
| Humans | 151 | 2025 | 63297 | 0.970 |
Why?
|
| Diffusion Tensor Imaging | 4 | 2023 | 74 | 0.960 |
Why?
|
| Biomedical Research | 6 | 2017 | 268 | 0.890 |
Why?
|
| Publishing | 6 | 2016 | 93 | 0.840 |
Why?
|
| Medical Informatics | 4 | 2018 | 73 | 0.830 |
Why?
|
| Datasets as Topic | 3 | 2019 | 27 | 0.790 |
Why?
|
| Access to Information | 4 | 2015 | 30 | 0.760 |
Why?
|
| Informatics | 4 | 2015 | 11 | 0.750 |
Why?
|
| National Institutes of Health (U.S.) | 6 | 2009 | 118 | 0.710 |
Why?
|
| Caregivers | 1 | 2024 | 271 | 0.700 |
Why?
|
| Social Behavior | 2 | 2016 | 90 | 0.680 |
Why?
|
| Adolescent | 49 | 2024 | 6238 | 0.680 |
Why?
|
| Pandemics | 2 | 2024 | 673 | 0.640 |
Why?
|
| Otolaryngology | 2 | 2016 | 29 | 0.630 |
Why?
|
| Male | 90 | 2024 | 29821 | 0.600 |
Why?
|
| Mentha piperita | 1 | 2018 | 3 | 0.600 |
Why?
|
| Terpenes | 1 | 2018 | 27 | 0.590 |
Why?
|
| Sinusitis | 3 | 2024 | 31 | 0.580 |
Why?
|
| Oils, Volatile | 1 | 2018 | 24 | 0.580 |
Why?
|
| Data Curation | 2 | 2016 | 5 | 0.570 |
Why?
|
| Adult | 59 | 2024 | 16784 | 0.570 |
Why?
|
| Plant Oils | 1 | 2018 | 58 | 0.570 |
Why?
|
| Neural Pathways | 9 | 2023 | 98 | 0.550 |
Why?
|
| Affect | 1 | 2018 | 125 | 0.550 |
Why?
|
| Gyrus Cinguli | 9 | 2015 | 57 | 0.550 |
Why?
|
| Young Adult | 30 | 2024 | 4683 | 0.540 |
Why?
|
| Functional Laterality | 14 | 2019 | 138 | 0.510 |
Why?
|
| Nerve Fibers, Myelinated | 5 | 2012 | 30 | 0.510 |
Why?
|
| Female | 78 | 2024 | 32791 | 0.500 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 12 | 2019 | 153 | 0.500 |
Why?
|
| Leadership | 1 | 2018 | 206 | 0.490 |
Why?
|
| Databases, Bibliographic | 1 | 2015 | 9 | 0.490 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2017 | 97 | 0.480 |
Why?
|
| Mobile Applications | 1 | 2017 | 136 | 0.470 |
Why?
|
| Aging | 8 | 2017 | 746 | 0.470 |
Why?
|
| Image Interpretation, Computer-Assisted | 4 | 2010 | 178 | 0.460 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 7 | 2013 | 159 | 0.450 |
Why?
|
| Autistic Disorder | 5 | 2021 | 151 | 0.450 |
Why?
|
| Autism Spectrum Disorder | 4 | 2022 | 180 | 0.430 |
Why?
|
| Neuropsychological Tests | 14 | 2018 | 391 | 0.430 |
Why?
|
| Rhinitis | 3 | 2024 | 25 | 0.420 |
Why?
|
| Models, Neurological | 6 | 2021 | 80 | 0.420 |
Why?
|
| MEDLINE | 1 | 2013 | 13 | 0.420 |
Why?
|
| Pediatrics | 2 | 2015 | 254 | 0.410 |
Why?
|
| Ataxia | 3 | 2017 | 23 | 0.410 |
Why?
|
| Bipolar Disorder | 7 | 2010 | 247 | 0.410 |
Why?
|
| Authorship | 1 | 2013 | 23 | 0.410 |
Why?
|
| Child | 28 | 2024 | 4522 | 0.410 |
Why?
|
| Glucose | 2 | 2014 | 467 | 0.400 |
Why?
|
| Stroke | 4 | 2020 | 1191 | 0.390 |
Why?
|
| Financing, Government | 2 | 2009 | 31 | 0.380 |
Why?
|
| Data Collection | 2 | 2025 | 384 | 0.380 |
Why?
|
| Information Systems | 1 | 2012 | 29 | 0.380 |
Why?
|
| Beta vulgaris | 2 | 2022 | 7 | 0.370 |
Why?
|
| Beverages | 1 | 2012 | 67 | 0.370 |
Why?
|
| Cooperative Behavior | 4 | 2019 | 222 | 0.370 |
Why?
|
| Prefrontal Cortex | 7 | 2015 | 122 | 0.360 |
Why?
|
| Limbic System | 6 | 2009 | 27 | 0.350 |
Why?
|
| Renal Replacement Therapy | 2 | 2024 | 24 | 0.350 |
Why?
|
| Refugees | 2 | 2022 | 70 | 0.340 |
Why?
|
| Adolescent Development | 2 | 2021 | 16 | 0.340 |
Why?
|
| Hippocampus | 9 | 2015 | 270 | 0.340 |
Why?
|
| Middle Aged | 37 | 2024 | 17553 | 0.320 |
Why?
|
| Frontal Lobe | 5 | 2013 | 64 | 0.320 |
Why?
|
| Attention | 6 | 2018 | 148 | 0.310 |
Why?
|
| Psychology, Adolescent | 2 | 2021 | 27 | 0.300 |
Why?
|
| Anxiety Disorders | 2 | 2024 | 192 | 0.300 |
Why?
|
| Qi | 1 | 2007 | 3 | 0.280 |
Why?
|
| Acupuncture Points | 1 | 2007 | 5 | 0.280 |
Why?
|
| Nerve Fibers, Unmyelinated | 1 | 2007 | 6 | 0.280 |
Why?
|
| Cross-Over Studies | 4 | 2018 | 161 | 0.280 |
Why?
|
| Mental Disorders | 2 | 2012 | 791 | 0.280 |
Why?
|
| Cerebellum | 6 | 2013 | 94 | 0.280 |
Why?
|
| Health Resources | 3 | 2016 | 95 | 0.280 |
Why?
|
| Sensation | 1 | 2007 | 19 | 0.280 |
Why?
|
| Mobility Limitation | 2 | 2017 | 49 | 0.270 |
Why?
|
| Aged | 23 | 2024 | 14394 | 0.260 |
Why?
|
| Temporal Lobe | 4 | 2015 | 45 | 0.260 |
Why?
|
| Image Enhancement | 3 | 2009 | 192 | 0.250 |
Why?
|
| Research | 2 | 2015 | 193 | 0.250 |
Why?
|
| Glomerular Filtration Rate | 2 | 2024 | 113 | 0.240 |
Why?
|
| Thalamus | 4 | 2019 | 72 | 0.240 |
Why?
|
| User-Computer Interface | 3 | 2012 | 125 | 0.240 |
Why?
|
| Child, Preschool | 10 | 2024 | 1988 | 0.240 |
Why?
|
| Reaction Time | 3 | 2014 | 124 | 0.230 |
Why?
|
| Lanthanoid Series Elements | 1 | 2024 | 8 | 0.230 |
Why?
|
| Gum Arabic | 1 | 2024 | 11 | 0.230 |
Why?
|
| Psychotic Disorders | 2 | 2019 | 158 | 0.230 |
Why?
|
| Albendazole | 1 | 2024 | 10 | 0.230 |
Why?
|
| Double-Blind Method | 3 | 2018 | 738 | 0.230 |
Why?
|
| Helminthiasis | 1 | 2024 | 6 | 0.230 |
Why?
|
| Mass Drug Administration | 1 | 2024 | 12 | 0.230 |
Why?
|
| United States | 12 | 2021 | 7826 | 0.230 |
Why?
|
| Soil | 1 | 2024 | 27 | 0.220 |
Why?
|
| Substance-Related Disorders | 3 | 2023 | 732 | 0.220 |
Why?
|
| Brain-Derived Neurotrophic Factor | 2 | 2014 | 35 | 0.220 |
Why?
|
| Reward | 4 | 2010 | 87 | 0.220 |
Why?
|
| Anthelmintics | 1 | 2024 | 44 | 0.220 |
Why?
|
| Urinary Tract | 1 | 2023 | 8 | 0.210 |
Why?
|
| Interprofessional Relations | 2 | 2015 | 134 | 0.210 |
Why?
|
| Surveys and Questionnaires | 5 | 2025 | 2674 | 0.210 |
Why?
|
| Seaweed | 1 | 2023 | 1 | 0.210 |
Why?
|
| Rhodophyta | 1 | 2023 | 2 | 0.210 |
Why?
|
| Kidney Calculi | 1 | 2023 | 34 | 0.210 |
Why?
|
| Alcoholism | 4 | 2021 | 318 | 0.210 |
Why?
|
| Chlorophyta | 1 | 2023 | 13 | 0.210 |
Why?
|
| Corpus Callosum | 3 | 2013 | 42 | 0.200 |
Why?
|
| Language Disorders | 3 | 2010 | 25 | 0.200 |
Why?
|
| Information Science | 1 | 2003 | 2 | 0.200 |
Why?
|
| Somatoform Disorders | 1 | 2003 | 13 | 0.200 |
Why?
|
| Population Surveillance | 1 | 2024 | 206 | 0.200 |
Why?
|
| Cocaine-Related Disorders | 4 | 2014 | 83 | 0.200 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2016 | 718 | 0.200 |
Why?
|
| Emotions | 2 | 2024 | 223 | 0.200 |
Why?
|
| Case-Control Studies | 11 | 2019 | 1121 | 0.200 |
Why?
|
| Nasal Polyps | 1 | 2022 | 10 | 0.200 |
Why?
|
| Evoked Potentials | 1 | 2002 | 39 | 0.200 |
Why?
|
| Alaska Natives | 1 | 2022 | 2 | 0.190 |
Why?
|
| Nitrates | 1 | 2022 | 21 | 0.190 |
Why?
|
| Overweight | 2 | 2022 | 250 | 0.190 |
Why?
|
| Indians, North American | 1 | 2022 | 29 | 0.190 |
Why?
|
| Algorithms | 8 | 2011 | 1001 | 0.190 |
Why?
|
| Infant, Newborn | 4 | 2022 | 1355 | 0.190 |
Why?
|
| Infant, Extremely Premature | 1 | 2022 | 37 | 0.190 |
Why?
|
| Sample Size | 2 | 2021 | 65 | 0.190 |
Why?
|
| Skull Base | 2 | 2019 | 14 | 0.190 |
Why?
|
| Contact Tracing | 1 | 2021 | 17 | 0.190 |
Why?
|
| Psychiatric Status Rating Scales | 10 | 2015 | 390 | 0.180 |
Why?
|
| Psychomotor Performance | 4 | 2019 | 137 | 0.180 |
Why?
|
| England | 2 | 2018 | 29 | 0.180 |
Why?
|
| Panax | 1 | 2021 | 2 | 0.180 |
Why?
|
| Zebrafish | 1 | 2024 | 347 | 0.180 |
Why?
|
| Epidemics | 1 | 2021 | 24 | 0.180 |
Why?
|
| Multimodal Imaging | 2 | 2019 | 67 | 0.180 |
Why?
|
| Organ Size | 7 | 2021 | 172 | 0.180 |
Why?
|
| Schools | 2 | 2021 | 166 | 0.180 |
Why?
|
| Sex Characteristics | 4 | 2012 | 203 | 0.180 |
Why?
|
| Rhinitis, Allergic | 1 | 2021 | 2 | 0.180 |
Why?
|
| Nitrites | 1 | 2021 | 11 | 0.180 |
Why?
|
| Nitrogen Oxides | 1 | 2021 | 11 | 0.180 |
Why?
|
| Fruit and Vegetable Juices | 1 | 2021 | 10 | 0.180 |
Why?
|
| Communicable Diseases | 1 | 2022 | 90 | 0.180 |
Why?
|
| Occipital Lobe | 2 | 2013 | 17 | 0.180 |
Why?
|
| Tobacco Use Disorder | 2 | 2014 | 246 | 0.180 |
Why?
|
| Cohort Studies | 10 | 2020 | 2568 | 0.170 |
Why?
|
| Endoscopy | 2 | 2019 | 110 | 0.170 |
Why?
|
| Language Development Disorders | 2 | 2016 | 27 | 0.170 |
Why?
|
| Vitamins | 1 | 2021 | 80 | 0.170 |
Why?
|
| Pilot Projects | 7 | 2022 | 1006 | 0.170 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 5 | 2012 | 120 | 0.170 |
Why?
|
| Electroencephalography | 2 | 2021 | 149 | 0.170 |
Why?
|
| Basal Ganglia | 3 | 2013 | 34 | 0.170 |
Why?
|
| Thiamine Deficiency | 1 | 2020 | 8 | 0.170 |
Why?
|
| Meta-Analysis as Topic | 3 | 2012 | 77 | 0.170 |
Why?
|
| Patient Satisfaction | 1 | 2023 | 433 | 0.170 |
Why?
|
| Rehabilitation Centers | 1 | 2020 | 14 | 0.170 |
Why?
|
| Thiamine | 1 | 2020 | 21 | 0.160 |
Why?
|
| Animals | 10 | 2024 | 20634 | 0.160 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 1 | 2019 | 13 | 0.160 |
Why?
|
| Calcium Signaling | 2 | 2018 | 158 | 0.160 |
Why?
|
| Parietal Lobe | 4 | 2014 | 28 | 0.160 |
Why?
|
| Stroke Rehabilitation | 1 | 2020 | 50 | 0.160 |
Why?
|
| Scholarly Communication | 1 | 2019 | 4 | 0.160 |
Why?
|
| Alpha Rhythm | 1 | 2019 | 3 | 0.150 |
Why?
|
| Search Engine | 2 | 2008 | 9 | 0.150 |
Why?
|
| Mentha spicata | 1 | 2018 | 1 | 0.150 |
Why?
|
| Cerebellar Cortex | 4 | 2010 | 10 | 0.150 |
Why?
|
| Peer Review, Research | 2 | 2009 | 47 | 0.150 |
Why?
|
| Forecasting | 2 | 2016 | 232 | 0.150 |
Why?
|
| Neurosurgical Procedures | 1 | 2019 | 99 | 0.150 |
Why?
|
| Receptors, GABA-A | 1 | 2018 | 25 | 0.150 |
Why?
|
| Family Health | 2 | 2010 | 69 | 0.150 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2018 | 47 | 0.140 |
Why?
|
| Aryldialkylphosphatase | 1 | 2018 | 19 | 0.140 |
Why?
|
| Statistics as Topic | 5 | 2017 | 147 | 0.140 |
Why?
|
| Amygdala | 3 | 2008 | 83 | 0.140 |
Why?
|
| Anisotropy | 7 | 2016 | 61 | 0.140 |
Why?
|
| Receptors, Nicotinic | 1 | 2018 | 67 | 0.140 |
Why?
|
| Functional Neuroimaging | 2 | 2019 | 14 | 0.140 |
Why?
|
| Brain Diseases | 2 | 2009 | 76 | 0.140 |
Why?
|
| Geriatric Assessment | 2 | 2017 | 163 | 0.140 |
Why?
|
| Interpersonal Relations | 1 | 2019 | 151 | 0.140 |
Why?
|
| Health Personnel | 1 | 2021 | 367 | 0.140 |
Why?
|
| Myocytes, Cardiac | 1 | 2018 | 96 | 0.140 |
Why?
|
| Imaging, Three-Dimensional | 6 | 2010 | 288 | 0.140 |
Why?
|
| Awards and Prizes | 1 | 2018 | 34 | 0.140 |
Why?
|
| Reference Values | 5 | 2015 | 335 | 0.140 |
Why?
|
| White Matter | 2 | 2016 | 123 | 0.140 |
Why?
|
| Nephrology | 1 | 2017 | 15 | 0.130 |
Why?
|
| Practice Guidelines as Topic | 1 | 2021 | 735 | 0.130 |
Why?
|
| Inpatients | 1 | 2020 | 303 | 0.130 |
Why?
|
| Reactive Oxygen Species | 1 | 2018 | 224 | 0.130 |
Why?
|
| Diagnostic Imaging | 3 | 2012 | 264 | 0.130 |
Why?
|
| Neurons | 2 | 2018 | 923 | 0.130 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2021 | 760 | 0.130 |
Why?
|
| Gait | 1 | 2017 | 119 | 0.130 |
Why?
|
| Accidental Falls | 1 | 2017 | 127 | 0.130 |
Why?
|
| Gray Matter | 1 | 2016 | 35 | 0.130 |
Why?
|
| Dyslexia | 1 | 2016 | 8 | 0.130 |
Why?
|
| Apolipoprotein E4 | 1 | 2016 | 46 | 0.130 |
Why?
|
| Cross-Sectional Studies | 6 | 2021 | 2571 | 0.130 |
Why?
|
| Oxidative Stress | 1 | 2018 | 297 | 0.130 |
Why?
|
| Laboratory Chemicals | 1 | 2015 | 1 | 0.120 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2021 | 479 | 0.120 |
Why?
|
| Observer Variation | 4 | 2010 | 213 | 0.120 |
Why?
|
| Cognition Disorders | 3 | 2007 | 217 | 0.120 |
Why?
|
| Memory | 3 | 2012 | 120 | 0.120 |
Why?
|
| Educational Status | 2 | 2015 | 275 | 0.120 |
Why?
|
| Equipment and Supplies | 1 | 2015 | 19 | 0.120 |
Why?
|
| Culture | 1 | 2016 | 78 | 0.120 |
Why?
|
| Hospitals, General | 1 | 2015 | 17 | 0.120 |
Why?
|
| Parents | 2 | 2021 | 390 | 0.120 |
Why?
|
| Avoidance Learning | 3 | 2010 | 26 | 0.120 |
Why?
|
| History, 21st Century | 2 | 2015 | 171 | 0.120 |
Why?
|
| Aged, 80 and over | 7 | 2017 | 5447 | 0.120 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2017 | 129 | 0.120 |
Why?
|
| Psychology, Child | 1 | 2015 | 7 | 0.120 |
Why?
|
| Genetics | 1 | 2015 | 13 | 0.120 |
Why?
|
| Kidney Failure, Chronic | 1 | 2017 | 205 | 0.120 |
Why?
|
| Methamphetamine | 1 | 2015 | 26 | 0.120 |
Why?
|
| Agenesis of Corpus Callosum | 1 | 2015 | 6 | 0.120 |
Why?
|
| Turner Syndrome | 1 | 2015 | 9 | 0.120 |
Why?
|
| Mathematics | 2 | 2012 | 34 | 0.120 |
Why?
|
| Situs Inversus | 1 | 2015 | 5 | 0.120 |
Why?
|
| Health Services Needs and Demand | 1 | 2016 | 209 | 0.120 |
Why?
|
| Family | 2 | 2010 | 238 | 0.120 |
Why?
|
| Grandparents | 1 | 2014 | 7 | 0.110 |
Why?
|
| Glutamine | 1 | 2015 | 46 | 0.110 |
Why?
|
| Obsessive-Compulsive Disorder | 2 | 2007 | 36 | 0.110 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2015 | 75 | 0.110 |
Why?
|
| Opioid-Related Disorders | 1 | 2022 | 506 | 0.110 |
Why?
|
| Age Factors | 6 | 2015 | 1560 | 0.110 |
Why?
|
| Terminology as Topic | 1 | 2015 | 141 | 0.110 |
Why?
|
| Homocysteine | 1 | 2014 | 33 | 0.110 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2015 | 45 | 0.110 |
Why?
|
| Folic Acid | 1 | 2014 | 41 | 0.110 |
Why?
|
| Depression | 2 | 2016 | 891 | 0.110 |
Why?
|
| Income | 1 | 2015 | 169 | 0.110 |
Why?
|
| Temperament | 1 | 2014 | 20 | 0.110 |
Why?
|
| Anger | 1 | 2014 | 23 | 0.110 |
Why?
|
| Cells, Cultured | 1 | 2018 | 2152 | 0.110 |
Why?
|
| Anxiety | 2 | 2015 | 424 | 0.110 |
Why?
|
| Rest | 2 | 2010 | 46 | 0.100 |
Why?
|
| Organizations | 1 | 2013 | 6 | 0.100 |
Why?
|
| Infant | 3 | 2015 | 1649 | 0.100 |
Why?
|
| Referral and Consultation | 1 | 2017 | 422 | 0.100 |
Why?
|
| Cocaine | 1 | 2014 | 101 | 0.100 |
Why?
|
| Socioeconomic Factors | 4 | 2021 | 777 | 0.100 |
Why?
|
| Methylphenidate | 1 | 2013 | 19 | 0.100 |
Why?
|
| Central Nervous System Stimulants | 1 | 2013 | 65 | 0.100 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2014 | 158 | 0.100 |
Why?
|
| Sex Factors | 6 | 2015 | 979 | 0.100 |
Why?
|
| Language Arts | 1 | 2012 | 1 | 0.100 |
Why?
|
| Feasibility Studies | 3 | 2021 | 568 | 0.100 |
Why?
|
| Analysis of Variance | 6 | 2010 | 608 | 0.100 |
Why?
|
| Retrospective Studies | 4 | 2020 | 6631 | 0.100 |
Why?
|
| Risk Factors | 7 | 2023 | 5343 | 0.100 |
Why?
|
| Genotype | 4 | 2016 | 664 | 0.100 |
Why?
|
| Research Design | 3 | 2021 | 573 | 0.100 |
Why?
|
| Oxygen | 4 | 2010 | 315 | 0.100 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2012 | 18 | 0.100 |
Why?
|
| Software Design | 1 | 2012 | 28 | 0.100 |
Why?
|
| Depressive Disorder | 1 | 2014 | 284 | 0.090 |
Why?
|
| Health Services Accessibility | 1 | 2017 | 563 | 0.090 |
Why?
|
| Artificial Intelligence | 3 | 2011 | 178 | 0.090 |
Why?
|
| Mortality, Premature | 1 | 2011 | 7 | 0.090 |
Why?
|
| Task Performance and Analysis | 1 | 2012 | 126 | 0.090 |
Why?
|
| Disease Progression | 4 | 2021 | 1168 | 0.090 |
Why?
|
| Species Specificity | 1 | 2012 | 334 | 0.090 |
Why?
|
| Child Development | 1 | 2012 | 85 | 0.090 |
Why?
|
| Single-Blind Method | 2 | 2022 | 143 | 0.090 |
Why?
|
| Community-Based Participatory Research | 1 | 2011 | 49 | 0.090 |
Why?
|
| Substantia Nigra | 1 | 2010 | 14 | 0.090 |
Why?
|
| Prevalence | 3 | 2024 | 1377 | 0.090 |
Why?
|
| Primary Health Care | 1 | 2016 | 690 | 0.080 |
Why?
|
| Ventral Tegmental Area | 1 | 2010 | 37 | 0.080 |
Why?
|
| Prospective Studies | 4 | 2022 | 3285 | 0.080 |
Why?
|
| Pattern Recognition, Visual | 1 | 2010 | 40 | 0.080 |
Why?
|
| Heart Failure | 1 | 2018 | 916 | 0.080 |
Why?
|
| Violence | 1 | 2011 | 170 | 0.080 |
Why?
|
| Radiology Information Systems | 1 | 2010 | 34 | 0.080 |
Why?
|
| Pain Measurement | 2 | 2009 | 345 | 0.080 |
Why?
|
| Genetic Variation | 1 | 2012 | 383 | 0.080 |
Why?
|
| Risk | 2 | 2007 | 377 | 0.080 |
Why?
|
| Chewing Gum | 1 | 2009 | 9 | 0.080 |
Why?
|
| Longitudinal Studies | 4 | 2018 | 1254 | 0.080 |
Why?
|
| Pattern Recognition, Automated | 1 | 2009 | 53 | 0.080 |
Why?
|
| Cephalometry | 1 | 2008 | 11 | 0.080 |
Why?
|
| Cerebrovascular Circulation | 3 | 2022 | 180 | 0.080 |
Why?
|
| Neuroradiography | 1 | 2008 | 11 | 0.080 |
Why?
|
| Databases as Topic | 1 | 2008 | 55 | 0.070 |
Why?
|
| Disruptive, Impulse Control, and Conduct Disorders | 1 | 2008 | 8 | 0.070 |
Why?
|
| Language | 1 | 2010 | 150 | 0.070 |
Why?
|
| Mood Disorders | 1 | 2009 | 72 | 0.070 |
Why?
|
| Models, Anatomic | 1 | 2008 | 64 | 0.070 |
Why?
|
| Head | 1 | 2008 | 55 | 0.070 |
Why?
|
| Depressive Disorder, Major | 1 | 2010 | 255 | 0.070 |
Why?
|
| Schizophrenia, Childhood | 1 | 2007 | 21 | 0.070 |
Why?
|
| Pain Threshold | 1 | 2007 | 25 | 0.070 |
Why?
|
| Hydrocortisone | 1 | 2009 | 193 | 0.070 |
Why?
|
| Analgesics, Opioid | 2 | 2023 | 536 | 0.070 |
Why?
|
| Extremities | 2 | 2017 | 44 | 0.070 |
Why?
|
| Linear Models | 4 | 2011 | 409 | 0.070 |
Why?
|
| Neuroglia | 1 | 2007 | 79 | 0.070 |
Why?
|
| Caudate Nucleus | 2 | 2007 | 25 | 0.070 |
Why?
|
| Schizophrenic Language | 1 | 2006 | 2 | 0.070 |
Why?
|
| Internal Capsule | 1 | 2007 | 11 | 0.070 |
Why?
|
| Severity of Illness Index | 4 | 2017 | 1543 | 0.070 |
Why?
|
| Trichotillomania | 1 | 2006 | 11 | 0.070 |
Why?
|
| Biomarkers | 3 | 2021 | 1396 | 0.070 |
Why?
|
| Verbal Behavior | 1 | 2006 | 36 | 0.060 |
Why?
|
| Brain Stem | 1 | 2006 | 28 | 0.060 |
Why?
|
| Hypothalamus | 1 | 2006 | 132 | 0.060 |
Why?
|
| Recurrence | 2 | 2023 | 642 | 0.060 |
Why?
|
| Aphasia | 1 | 2006 | 45 | 0.060 |
Why?
|
| Nerve Net | 1 | 2007 | 97 | 0.060 |
Why?
|
| Saliva | 2 | 2021 | 103 | 0.060 |
Why?
|
| Acupuncture | 1 | 2005 | 4 | 0.060 |
Why?
|
| Arousal | 1 | 2005 | 42 | 0.060 |
Why?
|
| Pituitary-Adrenal System | 1 | 2005 | 60 | 0.060 |
Why?
|
| Odds Ratio | 2 | 2017 | 768 | 0.060 |
Why?
|
| Speech Perception | 1 | 2006 | 79 | 0.060 |
Why?
|
| Menstrual Cycle | 1 | 2005 | 82 | 0.060 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2005 | 88 | 0.060 |
Why?
|
| Photic Stimulation | 3 | 2011 | 90 | 0.060 |
Why?
|
| Signal Processing, Computer-Assisted | 2 | 2019 | 96 | 0.060 |
Why?
|
| Medical Informatics Applications | 1 | 2005 | 14 | 0.060 |
Why?
|
| Dominance, Cerebral | 4 | 2007 | 33 | 0.060 |
Why?
|
| Time Factors | 2 | 2024 | 3762 | 0.060 |
Why?
|
| Benin | 1 | 2024 | 2 | 0.060 |
Why?
|
| Malawi | 1 | 2024 | 11 | 0.060 |
Why?
|
| Helminths | 1 | 2024 | 4 | 0.060 |
Why?
|
| Self Report | 2 | 2018 | 374 | 0.060 |
Why?
|
| Follow-Up Studies | 3 | 2021 | 2460 | 0.060 |
Why?
|
| Supratentorial Neoplasms | 1 | 2004 | 2 | 0.060 |
Why?
|
| Stress, Psychological | 1 | 2009 | 469 | 0.060 |
Why?
|
| Laryngopharyngeal Reflux | 1 | 2024 | 4 | 0.060 |
Why?
|
| Sensitivity and Specificity | 2 | 2009 | 1146 | 0.060 |
Why?
|
| Arteries | 1 | 2005 | 81 | 0.060 |
Why?
|
| United Kingdom | 1 | 2024 | 81 | 0.050 |
Why?
|
| India | 1 | 2024 | 158 | 0.050 |
Why?
|
| Regression Analysis | 3 | 2015 | 498 | 0.050 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2004 | 94 | 0.050 |
Why?
|
| Career Mobility | 1 | 2024 | 64 | 0.050 |
Why?
|
| Calcium Oxalate | 1 | 2023 | 13 | 0.050 |
Why?
|
| Logistic Models | 2 | 2017 | 1275 | 0.050 |
Why?
|
| Personnel Selection | 1 | 2024 | 55 | 0.050 |
Why?
|
| Surface Properties | 1 | 2024 | 278 | 0.050 |
Why?
|
| Geologic Sediments | 1 | 2023 | 4 | 0.050 |
Why?
|
| Uric Acid | 1 | 2023 | 47 | 0.050 |
Why?
|
| Glioma | 1 | 2004 | 98 | 0.050 |
Why?
|
| Radiopharmaceuticals | 1 | 2004 | 185 | 0.050 |
Why?
|
| Biocompatible Materials | 1 | 2024 | 150 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2014 | 451 | 0.050 |
Why?
|
| Obesity | 2 | 2022 | 1230 | 0.050 |
Why?
|
| Time-to-Treatment | 1 | 2024 | 111 | 0.050 |
Why?
|
| Epilepsy, Partial, Motor | 1 | 2003 | 1 | 0.050 |
Why?
|
| Mathematical Computing | 1 | 2003 | 12 | 0.050 |
Why?
|
| Computer Simulation | 2 | 2021 | 477 | 0.050 |
Why?
|
| Language Tests | 3 | 2010 | 39 | 0.050 |
Why?
|
| Comorbidity | 2 | 2021 | 1121 | 0.050 |
Why?
|
| Privacy | 1 | 2003 | 12 | 0.050 |
Why?
|
| Carbon | 1 | 2023 | 51 | 0.050 |
Why?
|
| Particle Size | 1 | 2024 | 407 | 0.050 |
Why?
|
| Evoked Potentials, Visual | 1 | 2002 | 13 | 0.050 |
Why?
|
| Intelligence Tests | 2 | 2017 | 26 | 0.050 |
Why?
|
| Cell Survival | 1 | 2024 | 569 | 0.050 |
Why?
|
| Stochastic Processes | 1 | 2002 | 27 | 0.050 |
Why?
|
| Ecosystem | 1 | 2023 | 53 | 0.050 |
Why?
|
| Encephalitis | 1 | 2003 | 34 | 0.050 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2024 | 153 | 0.050 |
Why?
|
| Quality Control | 1 | 2002 | 74 | 0.050 |
Why?
|
| Science | 1 | 2003 | 34 | 0.050 |
Why?
|
| Protons | 1 | 2022 | 64 | 0.050 |
Why?
|
| Bangladesh | 1 | 2021 | 21 | 0.050 |
Why?
|
| Immunization Programs | 1 | 2021 | 14 | 0.050 |
Why?
|
| Systems Analysis | 1 | 2021 | 10 | 0.050 |
Why?
|
| Intelligence | 2 | 2015 | 55 | 0.050 |
Why?
|
| Machine Learning | 1 | 2023 | 177 | 0.050 |
Why?
|
| Masks | 1 | 2021 | 23 | 0.050 |
Why?
|
| Kidney | 1 | 2024 | 447 | 0.050 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2016 | 491 | 0.050 |
Why?
|
| Selection Bias | 1 | 2021 | 23 | 0.050 |
Why?
|
| Sampling Studies | 1 | 2021 | 70 | 0.050 |
Why?
|
| Minerals | 1 | 2021 | 20 | 0.050 |
Why?
|
| Social Skills | 1 | 2021 | 10 | 0.040 |
Why?
|
| Huntington Disease | 1 | 2003 | 154 | 0.040 |
Why?
|
| Models, Psychological | 1 | 2021 | 97 | 0.040 |
Why?
|
| Developing Countries | 1 | 2021 | 95 | 0.040 |
Why?
|
| Infant, Premature | 1 | 2003 | 184 | 0.040 |
Why?
|
| Plasma | 1 | 2021 | 37 | 0.040 |
Why?
|
| Gene-Environment Interaction | 1 | 2021 | 49 | 0.040 |
Why?
|
| Health Policy | 1 | 2003 | 192 | 0.040 |
Why?
|
| Genome-Wide Association Study | 2 | 2014 | 359 | 0.040 |
Why?
|
| Urine | 1 | 2021 | 45 | 0.040 |
Why?
|
| Self Concept | 1 | 2021 | 111 | 0.040 |
Why?
|
| Propensity Score | 1 | 2021 | 156 | 0.040 |
Why?
|
| Focus Groups | 1 | 2022 | 303 | 0.040 |
Why?
|
| Fatigue | 1 | 2021 | 111 | 0.040 |
Why?
|
| Asthma | 1 | 2005 | 440 | 0.040 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2022 | 233 | 0.040 |
Why?
|
| Calcium | 1 | 2023 | 573 | 0.040 |
Why?
|
| Registries | 1 | 2024 | 888 | 0.040 |
Why?
|
| Eating | 1 | 2021 | 138 | 0.040 |
Why?
|
| Patient Selection | 2 | 2015 | 488 | 0.040 |
Why?
|
| Consensus | 1 | 2021 | 228 | 0.040 |
Why?
|
| Plant Extracts | 1 | 2021 | 172 | 0.040 |
Why?
|
| Schizophrenic Psychology | 2 | 2014 | 66 | 0.040 |
Why?
|
| Prodromal Symptoms | 1 | 2019 | 16 | 0.040 |
Why?
|
| Support Vector Machine | 1 | 2019 | 23 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2022 | 753 | 0.040 |
Why?
|
| Los Angeles | 1 | 2018 | 12 | 0.040 |
Why?
|
| Underage Drinking | 1 | 2018 | 5 | 0.040 |
Why?
|
| Marijuana Smoking | 1 | 2018 | 18 | 0.040 |
Why?
|
| Radiography | 2 | 2015 | 548 | 0.040 |
Why?
|
| Nanoparticles | 1 | 2024 | 518 | 0.040 |
Why?
|
| Dietary Supplements | 1 | 2021 | 234 | 0.040 |
Why?
|
| Guidelines as Topic | 1 | 2019 | 158 | 0.040 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2003 | 397 | 0.040 |
Why?
|
| Risk-Taking | 1 | 2018 | 162 | 0.040 |
Why?
|
| Bayes Theorem | 2 | 2011 | 122 | 0.030 |
Why?
|
| Semantics | 2 | 2008 | 57 | 0.030 |
Why?
|
| State Medicine | 1 | 2017 | 12 | 0.030 |
Why?
|
| Independent Living | 1 | 2017 | 51 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2018 | 325 | 0.030 |
Why?
|
| Systems Integration | 2 | 2008 | 26 | 0.030 |
Why?
|
| Early Medical Intervention | 1 | 2017 | 21 | 0.030 |
Why?
|
| Research Personnel | 1 | 2018 | 94 | 0.030 |
Why?
|
| Educational Measurement | 1 | 2018 | 217 | 0.030 |
Why?
|
| Preventive Health Services | 1 | 2017 | 75 | 0.030 |
Why?
|
| Postural Balance | 1 | 2017 | 65 | 0.030 |
Why?
|
| Heart Transplantation | 1 | 2018 | 169 | 0.030 |
Why?
|
| PubMed | 1 | 2016 | 9 | 0.030 |
Why?
|
| Clinical Protocols | 1 | 2017 | 139 | 0.030 |
Why?
|
| Thiolester Hydrolases | 1 | 2016 | 9 | 0.030 |
Why?
|
| Genotyping Techniques | 1 | 2016 | 21 | 0.030 |
Why?
|
| Models, Statistical | 2 | 2011 | 309 | 0.030 |
Why?
|
| Data Accuracy | 1 | 2016 | 32 | 0.030 |
Why?
|
| Audiology | 1 | 2015 | 4 | 0.030 |
Why?
|
| Biomedical Engineering | 1 | 2015 | 7 | 0.030 |
Why?
|
| Hospital Departments | 1 | 2015 | 12 | 0.030 |
Why?
|
| Neurotology | 1 | 2015 | 6 | 0.030 |
Why?
|
| Vestibule, Labyrinth | 1 | 2015 | 10 | 0.030 |
Why?
|
| Maryland | 1 | 2015 | 35 | 0.030 |
Why?
|
| Cell Adhesion Molecules | 1 | 2016 | 90 | 0.030 |
Why?
|
| Face | 1 | 2015 | 38 | 0.030 |
Why?
|
| Hearing | 1 | 2015 | 34 | 0.030 |
Why?
|
| Surgery, Plastic | 1 | 2015 | 19 | 0.030 |
Why?
|
| Cloud Computing | 1 | 2015 | 4 | 0.030 |
Why?
|
| Disease Management | 1 | 2017 | 232 | 0.030 |
Why?
|
| Cluster Analysis | 2 | 2006 | 263 | 0.030 |
Why?
|
| Neurology | 1 | 2015 | 41 | 0.030 |
Why?
|
| Psychological Tests | 1 | 2015 | 46 | 0.030 |
Why?
|
| Pan troglodytes | 1 | 2015 | 32 | 0.030 |
Why?
|
| Antibodies | 1 | 2016 | 182 | 0.030 |
Why?
|
| Anthropometry | 1 | 2015 | 86 | 0.030 |
Why?
|
| Bronchoscopy | 1 | 2015 | 88 | 0.030 |
Why?
|
| Models, Animal | 1 | 2016 | 236 | 0.030 |
Why?
|
| Creatinine | 1 | 2015 | 136 | 0.030 |
Why?
|
| Workflow | 1 | 2015 | 69 | 0.030 |
Why?
|
| Blood Chemical Analysis | 1 | 2014 | 22 | 0.030 |
Why?
|
| Immunoassay | 1 | 2014 | 70 | 0.030 |
Why?
|
| History, 20th Century | 1 | 2015 | 231 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 1 | 2014 | 7 | 0.030 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2015 | 294 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2014 | 18 | 0.030 |
Why?
|
| Hostility | 1 | 2014 | 18 | 0.030 |
Why?
|
| Atrophy | 2 | 2005 | 83 | 0.030 |
Why?
|
| Head and Neck Neoplasms | 1 | 2015 | 168 | 0.030 |
Why?
|
| Verbal Learning | 2 | 2005 | 20 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2017 | 863 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2016 | 424 | 0.030 |
Why?
|
| Aggression | 1 | 2014 | 64 | 0.030 |
Why?
|
| Incidence | 1 | 2017 | 1375 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2018 | 2107 | 0.030 |
Why?
|
| Poverty | 1 | 2015 | 296 | 0.020 |
Why?
|
| Multivariate Analysis | 2 | 2005 | 935 | 0.020 |
Why?
|
| Quality Improvement | 1 | 2017 | 442 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 860 | 0.020 |
Why?
|
| Visual Cortex | 1 | 2012 | 26 | 0.020 |
Why?
|
| Psychometrics | 1 | 2013 | 375 | 0.020 |
Why?
|
| Homeostasis | 1 | 2014 | 370 | 0.020 |
Why?
|
| Medial Forebrain Bundle | 1 | 2010 | 3 | 0.020 |
Why?
|
| Anatomy, Cross-Sectional | 1 | 2010 | 8 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2012 | 260 | 0.020 |
Why?
|
| Myelin Sheath | 1 | 2010 | 37 | 0.020 |
Why?
|
| Beauty | 1 | 2010 | 1 | 0.020 |
Why?
|
| Rats, Long-Evans | 1 | 2010 | 22 | 0.020 |
Why?
|
| Proteins | 1 | 2016 | 751 | 0.020 |
Why?
|
| Consciousness | 1 | 2010 | 12 | 0.020 |
Why?
|
| DNA | 1 | 2015 | 832 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2017 | 2076 | 0.020 |
Why?
|
| Health Status Disparities | 1 | 2011 | 145 | 0.020 |
Why?
|
| Wakefulness | 1 | 2010 | 42 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2010 | 194 | 0.020 |
Why?
|
| Food | 1 | 2010 | 77 | 0.020 |
Why?
|
| Internal-External Control | 1 | 2009 | 33 | 0.020 |
Why?
|
| Prognosis | 1 | 2013 | 1750 | 0.020 |
Why?
|
| Electromagnetic Fields | 1 | 2008 | 14 | 0.020 |
Why?
|
| Genomics | 1 | 2012 | 370 | 0.020 |
Why?
|
| Social Support | 1 | 2011 | 371 | 0.020 |
Why?
|
| Personality Disorders | 1 | 2008 | 20 | 0.020 |
Why?
|
| Natural Language Processing | 1 | 2008 | 48 | 0.020 |
Why?
|
| Behavior, Addictive | 1 | 2008 | 73 | 0.020 |
Why?
|
| Fornix, Brain | 1 | 2007 | 10 | 0.020 |
Why?
|
| Documentation | 1 | 2008 | 128 | 0.020 |
Why?
|
| Corpus Striatum | 1 | 2008 | 97 | 0.020 |
Why?
|
| International Classification of Diseases | 1 | 2008 | 137 | 0.020 |
Why?
|
| Putamen | 1 | 2007 | 21 | 0.020 |
Why?
|
| Age of Onset | 1 | 2007 | 174 | 0.020 |
Why?
|
| Globus Pallidus | 1 | 2007 | 26 | 0.020 |
Why?
|
| Healthcare Disparities | 1 | 2011 | 357 | 0.020 |
Why?
|
| Pyramidal Tracts | 1 | 2007 | 25 | 0.020 |
Why?
|
| Pregnancy | 1 | 2014 | 2330 | 0.020 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2012 | 559 | 0.020 |
Why?
|
| Nucleus Accumbens | 1 | 2007 | 43 | 0.020 |
Why?
|
| Phonetics | 1 | 2006 | 30 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2008 | 317 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2006 | 214 | 0.020 |
Why?
|
| Rats | 1 | 2010 | 1977 | 0.020 |
Why?
|
| Body Height | 1 | 2006 | 68 | 0.020 |
Why?
|
| Information Management | 1 | 2006 | 12 | 0.020 |
Why?
|
| Psychophysics | 1 | 2005 | 9 | 0.020 |
Why?
|
| Nonlinear Dynamics | 1 | 2005 | 25 | 0.020 |
Why?
|
| Posture | 1 | 2006 | 127 | 0.020 |
Why?
|
| Calibration | 1 | 2005 | 66 | 0.020 |
Why?
|
| Gestational Age | 1 | 2006 | 189 | 0.020 |
Why?
|
| Telencephalon | 1 | 2005 | 10 | 0.020 |
Why?
|
| Touch | 1 | 2005 | 27 | 0.020 |
Why?
|
| Demography | 1 | 2006 | 173 | 0.010 |
Why?
|
| Macaca mulatta | 1 | 2006 | 251 | 0.010 |
Why?
|
| Multicenter Studies as Topic | 1 | 2005 | 137 | 0.010 |
Why?
|
| Oximetry | 1 | 2005 | 48 | 0.010 |
Why?
|
| Tomography, Emission-Computed | 1 | 2004 | 41 | 0.010 |
Why?
|
| Body Weight | 1 | 2006 | 377 | 0.010 |
Why?
|
| Mental Recall | 1 | 2005 | 93 | 0.010 |
Why?
|
| Motor Cortex | 1 | 2004 | 71 | 0.010 |
Why?
|
| Mice | 1 | 2018 | 10827 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2006 | 730 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2005 | 248 | 0.010 |
Why?
|
| Hemoglobins | 1 | 2005 | 135 | 0.010 |
Why?
|
| Markov Chains | 1 | 2004 | 37 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2004 | 242 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2014 | 3033 | 0.010 |
Why?
|
| Pain Management | 1 | 2005 | 161 | 0.010 |
Why?
|
| Factor Analysis, Statistical | 1 | 2003 | 96 | 0.010 |
Why?
|
| Ambulatory Care | 1 | 2005 | 311 | 0.010 |
Why?
|
| Glioblastoma | 1 | 2004 | 158 | 0.010 |
Why?
|
| Pain | 1 | 2005 | 406 | 0.010 |
Why?
|
| ROC Curve | 1 | 2003 | 281 | 0.010 |
Why?
|
| Memory Disorders | 1 | 2002 | 50 | 0.010 |
Why?
|
| Phenotype | 1 | 2003 | 1200 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2006 | 1618 | 0.010 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2005 | 694 | 0.010 |
Why?
|
| Alzheimer Disease | 1 | 2002 | 721 | 0.010 |
Why?
|